Celldex Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Celldex Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q2 2024.
  • Celldex Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $107K, unchanged year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $107K $0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $107K +$3K +2.89% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $107K +$3K +2.89% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $107K +$3K +2.89% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $107K +$3K +2.89% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $104K $0 0% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $104K $0 0% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $104K +$6K +6.12% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $104K +$63K +154% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $104K +$63K +154% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $104K +$63K +154% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $98K +$57K +139% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $41K $0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $41K $0 0% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $41K $0 0% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $41K -$88K -68.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $41K -$88K -68.2% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $41K -$88K -68.2% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $41K -$1.89M -97.9% Dec 31, 2019 10-K 2021-03-29
Q3 2019 $129K -$1.8M -93.3% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $129K -$1.8M -93.3% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $129K -$1.8M -93.3% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $1.93M $0 0% Dec 31, 2018 10-K 2020-03-26
Q3 2018 $1.93M -$73K -3.65% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $1.93M -$6K -0.31% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $1.93M -$6K -0.31% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.93M -$205K -9.61% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $2M +$123K +6.55% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $1.94M +$56K +2.98% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $1.94M +$1.86M +2381% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $2.13M +$706K +49.4% Dec 31, 2016 10-K 2018-03-07
Q3 2016 $1.88M +$379K +25.3% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.88M +$203K +12.1% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $78K -$1.74M -95.7% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 $1.43M -$294K -17.1% Dec 31, 2015 10-K 2017-03-14
Q3 2015 $1.5M +$1.4M +1415% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $1.68M +$1.56M +1345% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $1.82M +$1.68M +1276% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $1.72M +$1.57M +1064% Dec 31, 2014 10-K/A 2016-02-25
Q3 2014 $99K -$58K -36.9% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $116K -$58K -33.3% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $132K -$104K -44.1% Mar 31, 2014 10-Q 2014-05-01
Q4 2013 $148K -$276K -65.1% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $157K -$252K -61.6% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 $174K -$254K -59.3% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $236K -$224K -48.7% Mar 31, 2013 10-Q 2013-05-03
Q4 2012 $424K +$95K +28.9% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $409K +$61K +17.5% Sep 30, 2012 10-Q 2012-11-02
Q2 2012 $428K +$61K +16.6% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 $460K Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $329K -$34K -9.37% Dec 31, 2011 10-K 2013-03-08
Q3 2011 $348K Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $367K Jun 30, 2011 10-Q 2011-08-04
Q4 2010 $363K Dec 31, 2010 10-K 2012-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.